Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Mesa Laboratories Dividend Announcement
• Mesa Laboratories announced a quarterly dividend of $0.16 per ordinary share which will be made payable on 2024-12-16. Ex dividend date: 2024-11-29
• Mesa Laboratories annual dividend for 2024 was $0.64
• Mesa Laboratories annual dividend for 2023 was $0.64
• Mesa Laboratories's trailing twelve-month (TTM) dividend yield is 0.56%
• Mesa Laboratories's payout ratio for the trailing twelve months (TTM) is -1.41%
• Mesa Laboratories's dividend growth over the last ten years (2013-2023) was 1.17% year
Mesa Laboratories Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-29 | $0.16 | quarterly | 2024-12-16 |
2024-08-30 | $0.16 | quarterly | 2024-09-16 |
2024-05-31 | $0.16 | quarterly | 2024-06-14 |
2024-02-28 | $0.16 | quarterly | 2024-03-15 |
2023-11-29 | $0.16 | quarterly | 2023-12-15 |
2023-08-30 | $0.16 | quarterly | 2023-09-15 |
2023-05-30 | $0.16 | quarterly | 2023-06-15 |
2023-02-27 | $0.16 | quarterly | 2023-03-15 |
2022-11-29 | $0.16 | quarterly | 2022-12-15 |
2022-08-30 | $0.16 | quarterly | 2022-09-15 |
2022-05-27 | $0.16 | quarterly | 2022-06-15 |
2022-02-25 | $0.16 | quarterly | 2022-03-15 |
2021-11-29 | $0.16 | quarterly | 2021-12-15 |
2021-08-30 | $0.16 | quarterly | 2021-09-15 |
2021-05-27 | $0.16 | quarterly | 2021-06-15 |
2021-02-25 | $0.16 | quarterly | 2021-03-15 |
2020-11-27 | $0.16 | quarterly | 2020-12-15 |
2020-08-28 | $0.16 | quarterly | 2020-09-15 |
2020-05-28 | $0.16 | quarterly | 2020-06-15 |
2020-02-27 | $0.16 | quarterly | 2020-03-16 |
2019-11-27 | $0.16 | quarterly | 2019-12-16 |
2019-08-29 | $0.16 | quarterly | 2019-09-16 |
2019-05-30 | $0.16 | quarterly | 2019-06-14 |
2019-02-27 | $0.16 | quarterly | 2019-03-15 |
2018-11-29 | $0.16 | quarterly | 2018-12-17 |
2018-08-30 | $0.16 | quarterly | 2018-09-17 |
2018-05-30 | $0.16 | quarterly | 2018-06-15 |
2018-02-27 | $0.16 | quarterly | 2018-03-15 |
2017-11-29 | $0.16 | quarterly | 2017-12-15 |
2017-08-29 | $0.16 | quarterly | 2017-09-15 |
2017-05-26 | $0.16 | quarterly | 2017-06-15 |
2017-02-24 | $0.16 | quarterly | 2017-03-15 |
2016-11-28 | $0.16 | quarterly | 2016-12-15 |
2016-08-29 | $0.16 | quarterly | 2016-09-15 |
2016-05-26 | $0.16 | quarterly | 2016-06-15 |
2016-02-25 | $0.16 | quarterly | 2016-03-15 |
2015-11-25 | $0.16 | quarterly | 2015-12-15 |
2015-08-27 | $0.16 | quarterly | 2015-09-15 |
2015-05-27 | $0.16 | quarterly | 2015-06-15 |
2015-02-25 | $0.16 | quarterly | 2015-03-16 |
2014-11-25 | $0.16 | quarterly | 2014-12-15 |
2014-08-27 | $0.15 | quarterly | 2014-09-15 |
2014-05-28 | $0.15 | quarterly | 2014-06-16 |
2014-02-26 | $0.15 | quarterly | 2014-03-17 |
2013-11-26 | $0.15 | quarterly | 2013-12-16 |
2013-08-28 | $0.14 | quarterly | 2013-09-18 |
2013-05-22 | $0.14 | quarterly | 2013-06-14 |
2013-02-25 | $0.14 | quarterly | 2013-03-15 |
Mesa Laboratories Dividend per year
Mesa Laboratories Dividend growth
Mesa Laboratories Dividend Yield
Mesa Laboratories current trailing twelve-month (TTM) dividend yield is 0.56%. Interested in purchasing Mesa Laboratories stock? Use our calculator to estimate your expected dividend yield:
Mesa Laboratories Financial Ratios
Mesa Laboratories Dividend FAQ
Other factors to consider when evaluating Mesa Laboratories as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Mesa Laboratories stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Mesa Laboratories's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Mesa Laboratories publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Mesa Laboratories distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Mesa Laboratories are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Mesa Laboratories sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Mesa Laboratories distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Mesa Laboratories declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Mesa Laboratories's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Mesa Laboratories's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.